U.S. cases rarely delve into international patent law issues. Rather, US courts have largely refused to allow parallel proceedings or filings in foreign jurisdictions to impact their decision-making at home.
IBSA Institut Biochimique, v. Teva Pharmaceuticals offers an interesting Read More>>
Categories Patent
